Ex parte MICHEL GAY, et al. - Page 2




                Appeal No. 94-0825                                                                                                            
                Application 07/908,860                                                                                                        


                consideration due to a requirement for restriction (see the                                                                   
                brief, page 1, and 37 CFR § 1.142(b)).                                                                                        
                         The subject matter on appeal is drawn to siloxane compounds                                                          
                with a tetramethyl-piperidyl substituent (brief, pages 2-3, and                                                               
                appealed claim 17).  As noted by appellants on page 4 of the                                                                  
                brief, the claims stand or fall together.  The subject matter on                                                              
                appeal is adequately represented by appealed claim 17, which is                                                               
                reproduced and attached to this decision as an Appendix.                                                                      
                         The reference relied upon by the examiner is:                                                                        
                Nohr et al. (Nohr)       8932719-A            Oct. 19, 1989                                                                   
                (Australian)2                                                                                                                 
                         Claims 17 to 20 stand rejected under 35 U.S.C. § 102(g) as                                                           
                being anticipated by Australian Patent application 8932719-A,                                                                 
                which claims priority to abandoned U.S. Patent Application Number                                                             
                07/181,623.   We reverse this rejection.3                                                                                                          




                         2Actually the Australian Patent application 8932719-A has                                                            
                never been put into this application record but the examiner has                                                              
                relied upon a Derwent Abstract of this Australian Patent                                                                      
                application.  The date of this abstract is not part of the record                                                             
                but is immaterial to our decision.                                                                                            
                         3The final rejection also included a rejection of claims 17                                                          
                to 20 under 35 U.S.C. § 102(a) over abandoned application number                                                              
                07/181,623.  This rejection was withdrawn by the examiner in the                                                              
                Advisory Action dated April 26, 1993.                                                                                         
                                                                      2                                                                       





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007